Trexquant Investment LP Purchases New Shares in Envista Holdings Co. (NYSE:NVST)

Trexquant Investment LP bought a new position in shares of Envista Holdings Co. (NYSE:NVST - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 310,124 shares of the company's stock, valued at approximately $5,982,000. Trexquant Investment LP owned approximately 0.18% of Envista at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of NVST. Franklin Resources Inc. raised its stake in shares of Envista by 72.6% during the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock worth $132,223,000 after buying an additional 2,882,844 shares during the last quarter. Norges Bank bought a new stake in shares of Envista during the 4th quarter valued at $38,052,000. Pzena Investment Management LLC acquired a new position in shares of Envista in the 4th quarter valued at $16,979,000. Raymond James Financial Inc. bought a new position in shares of Envista in the 4th quarter worth $10,808,000. Finally, Lightrock Netherlands B.V. acquired a new stake in shares of Envista during the fourth quarter worth $5,193,000.

Wall Street Analysts Forecast Growth

NVST has been the topic of a number of recent analyst reports. Needham & Company LLC restated a "hold" rating on shares of Envista in a report on Thursday, March 6th. New Street Research set a $19.00 price objective on shares of Envista in a report on Thursday, March 6th. Morgan Stanley cut their target price on shares of Envista from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Thursday, March 6th. UBS Group lowered their price objective on shares of Envista from $23.00 to $21.00 and set a "neutral" rating for the company in a research report on Monday, March 10th. Finally, Piper Sandler lifted their target price on Envista from $17.00 to $18.00 and gave the stock a "neutral" rating in a report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $20.18.

Remove Ads

Envista Stock Down 6.5 %

Shares of Envista stock traded down $1.06 on Thursday, reaching $15.38. 1,250,008 shares of the company were exchanged, compared to its average volume of 2,835,983. Envista Holdings Co. has a one year low of $14.22 and a one year high of $23.00. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The company has a 50-day moving average of $18.59 and a 200 day moving average of $19.40. The company has a market capitalization of $2.65 billion, a price-to-earnings ratio of -2.37, a PEG ratio of 1.27 and a beta of 1.12.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, equities research analysts forecast that Envista Holdings Co. will post 1 earnings per share for the current year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.